Northern Trust’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.51M | Sell |
324,628
-14,022
| -4% | -$281K | ﹤0.01% | 2319 |
|
|
2025
Q1 | $6.66M | Buy |
338,650
+7,150
| +2% | +$141K | ﹤0.01% | 2272 |
|
|
2024
Q4 | $7.46M | Buy |
331,500
+27,104
| +9% | +$610K | ﹤0.01% | 2291 |
|
|
2024
Q3 | $7.77M | Buy |
304,396
+76,629
| +34% | +$1.96M | ﹤0.01% | 2218 |
|
|
2024
Q2 | $5.32M | Buy |
227,767
+9,009
| +4% | +$211K | ﹤0.01% | 2359 |
|
|
2024
Q1 | $3.85M | Sell |
218,758
-6,054
| -3% | -$106K | ﹤0.01% | 2630 |
|
|
2023
Q4 | $3.11M | Buy |
224,812
+30,278
| +16% | +$419K | ﹤0.01% | 2750 |
|
|
2023
Q3 | $2.66M | Sell |
194,534
-1,406
| -0.7% | -$19.2K | ﹤0.01% | 2783 |
|
|
2023
Q2 | $4M | Buy |
+195,940
| New | +$4M | ﹤0.01% | 2622 |
|
|
2023
Q1 | – | Sell |
-6,674
| Closed | -$109K | – | 4594 |
|
|
2022
Q4 | $109K | Buy |
6,674
+2,845
| +74% | +$46.5K | ﹤0.01% | 4064 |
|
|
2022
Q3 | $35K | Hold |
3,829
| – | – | ﹤0.01% | 4419 |
|
|
2022
Q2 | $19K | Hold |
3,829
| – | – | ﹤0.01% | 4633 |
|
|
2022
Q1 | $29K | Hold |
3,829
| – | – | ﹤0.01% | 4623 |
|
|
2021
Q4 | $34K | Hold |
3,829
| – | – | ﹤0.01% | 4646 |
|
|
2021
Q3 | $62K | Buy |
+3,829
| New | +$62K | ﹤0.01% | 4493 |
|
|
2021
Q2 | – | Sell |
-19,464
| Closed | -$657K | – | 4605 |
|
|
2021
Q1 | $657K | Sell |
19,464
-1,098
| -5% | -$37.1K | ﹤0.01% | 3737 |
|
|
2020
Q4 | $1.81M | Buy |
20,562
+5,292
| +35% | +$467K | ﹤0.01% | 3237 |
|
|
2020
Q3 | $1.24M | Sell |
15,270
-786
| -5% | -$64K | ﹤0.01% | 3298 |
|
|
2020
Q2 | $1.77M | Buy |
16,056
+14,408
| +874% | +$1.59M | ﹤0.01% | 3100 |
|
|
2020
Q1 | $106K | Buy |
+1,648
| New | +$106K | ﹤0.01% | 3804 |
|